SO-28 A randomized phase II trial of mFOLFOX6-based standard of care alone or in combination with Ad-CEA vaccine plus avelumab in patients with previously untreated metastatic colorectal cancer

Autor:	H. Abdul Sater, Jason M. Redman, Ravi A. Madan, Benjamin A. Weinberg, J. Schlom, J.-M. Lee, Fatima Karzai, Margaret E. Gatti-Mays, Lisa M. Cordes, Shahrooz Rabizadeh, Seth M. Steinberg, Patrick Soon-Shiong, Jennifer L. Marte, Renee N. Donahue, S. Gandhy, Yo-Ting Tsai, John L. Marshall, Julius Strauss, Sheri McMahon, Sunnie S. Kim, Marijo Bilusic, James L. Gulley
Rok vydání:	2020
Předmět:	Oncology medicine.medical_specialty Standard of care Colorectal cancer business.industry Hematology CEA Vaccine medicine.disease Avelumab Internal medicine medicine In patient business medicine.drug
Zdroj:	Annals of Oncology. 31:S227
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2020.04.043
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::a9c702f9077dea7b4f513394fceae04c https://doi.org/10.1016/j.annonc.2020.04.043 Zobrazit plný text záznamu